Anu Airaksinen

Anu Airaksinen serves as a Professor at the PET Center of the University of Turku, Finland, with contact details including email anu.airaksinen@utu.fi and telephone numbers +358 29 450 2199 and +358 50 470 7622. She leads the Radiopharmaceutical Chemistry Research Group, focusing on translational nuclear medicine applications.

Her research spans radiopharmaceutical chemistry, PET radiochemistry, image-assisted drug delivery, pretargeted PET imaging, theranostics, and nanotheranostics. Key methodologies include prosthetic group design, bioorthogonal chemistry, and nanocarrier development for precision oncology applications. Current projects target glioblastoma, colorectal cancer, breast cancer, and brain metastasis through innovative radiotracer platforms.

Recent publications (2023-2025) reveal strong trends in tumor-targeted nanotheranostics, particularly spherical nucleic acids and pretargeted imaging strategies using trans-cyclooctene/tetrazine systems. Her work bridges radiochemistry and clinical oncology, emphasizing boron neutron capture therapy agents and fatty acid binding protein imaging probes across EJNMMI Radiopharmacy and Chemistry, ACS Omega, and Nuclear Medicine and Biology.

Collaborative networks span multidisciplinary teams across oncology, biochemistry, and nanotechnology domains. Her leadership in the Radiopharmaceutical Chemistry Research Group drives advancements in molecular imaging probe design and therapeutic applications, with emphasis on clinical translation of novel radioconjugates.